The Cooper Companies, Inc. (NASDAQ:COO) Position Cut by Elo Mutual Pension Insurance Co

Elo Mutual Pension Insurance Co lowered its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 0.8% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,875 shares of the medical device company’s stock after selling 141 shares during the period. Elo Mutual Pension Insurance Co’s holdings in Cooper Companies were worth $1,560,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Treasurer of the State of North Carolina boosted its holdings in shares of Cooper Companies by 0.9% in the fourth quarter. Treasurer of the State of North Carolina now owns 22,861 shares of the medical device company’s stock valued at $8,652,000 after acquiring an additional 212 shares in the last quarter. Hsbc Holdings PLC lifted its position in Cooper Companies by 55.3% in the fourth quarter. Hsbc Holdings PLC now owns 87,718 shares of the medical device company’s stock worth $33,188,000 after purchasing an additional 31,234 shares during the period. Quantbot Technologies LP bought a new position in Cooper Companies during the 1st quarter valued at $2,211,000. Whittier Trust Co. increased its position in shares of Cooper Companies by 298.9% during the 1st quarter. Whittier Trust Co. now owns 11,940 shares of the medical device company’s stock valued at $1,211,000 after purchasing an additional 8,947 shares during the period. Finally, Envestnet Portfolio Solutions Inc. raised its stake in shares of Cooper Companies by 43.1% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 35,233 shares of the medical device company’s stock worth $3,076,000 after buying an additional 10,616 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Insider Buying and Selling

In other Cooper Companies news, CAO Agostino Ricupati sold 1,601 shares of the business’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total value of $172,956.03. Following the transaction, the chief accounting officer now owns 4,818 shares in the company, valued at $520,488.54. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CEO Albert G. White III sold 114,992 shares of the firm’s stock in a transaction on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the transaction, the chief executive officer now owns 165,273 shares in the company, valued at approximately $18,267,624.69. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Agostino Ricupati sold 1,601 shares of Cooper Companies stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the completion of the sale, the chief accounting officer now directly owns 4,818 shares of the company’s stock, valued at approximately $520,488.54. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 256,373 shares of company stock worth $27,637,427. Corporate insiders own 2.00% of the company’s stock.

Analyst Ratings Changes

COO has been the topic of a number of research analyst reports. Stifel Nicolaus reaffirmed a “buy” rating and set a $115.00 target price (up from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Robert W. Baird boosted their target price on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a report on Thursday, August 29th. Morgan Stanley raised their target price on shares of Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a report on Tuesday, September 10th. Jefferies Financial Group raised Cooper Companies from a “hold” rating to a “buy” rating and upped their price target for the company from $107.00 to $115.00 in a report on Tuesday, July 16th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th. Four analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $115.00.

Cooper Companies Stock Performance

Shares of Cooper Companies stock opened at $110.49 on Friday. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The Cooper Companies, Inc. has a 12 month low of $75.93 and a 12 month high of $112.38. The business has a fifty day simple moving average of $97.54 and a 200-day simple moving average of $95.48. The stock has a market cap of $22.00 billion, a PE ratio of 64.99, a price-to-earnings-growth ratio of 2.60 and a beta of 0.98.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.91 by $0.05. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The business had revenue of $1 billion during the quarter, compared to analysts’ expectations of $997.30 million. During the same period last year, the company posted $0.84 earnings per share. The firm’s quarterly revenue was up 7.8% compared to the same quarter last year. On average, sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.66 EPS for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.